AIM ImmunoTech Inc.
AIMNYSEAMERICANHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $2.92M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.16$2.79
- Volume (live)
- -
- Avg. volume (3M)
- 2.89M
AIM ImmunoTech (AIM) Stock Price & Financial Analysis
AIM ImmunoTech Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.16 - $0.18 |
|---|---|
| 52-Week High | $2.79 |
| 52-Week Low | $0.16 |
| Open | $0.16 |
| Volume (last close) | 1.03M |
| Average Volume (3M) | 2.89M |
| Revenue (TTM) | 90.00K |
|---|---|
| Net Income (TTM) | -15.16M |
| Free Cash Flow (TTM) | -4.16M |
| EPS (TTM) | −$2.21 |
| Profit Margin | -16845.56% |
| Operating Margin | -12936.67% |
| Return on Equity (ROE) | -195.78% |
| Debt to Equity | 0.51 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 2.92M |
|---|---|
| Shares Outstanding | 17.12M |
| Price to Sales (P/S) | 32.39 |
| Price to Book (P/B) | 0.38 |
| EV/EBITDA | 0.23 |
| 50-Day MA | $0.22 |
|---|---|
| 200-Day MA | $0.55 |
| 1-Year Change | −93.27% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
AIM ImmunoTech at a Glance
As of the Oct 15, 2026 close, AIM ImmunoTech (AIM) has a market capitalization of $2.92M. The stock trades at 32.4× sales. Over the trailing twelve months it lost $15.16M on revenue of $90.00K and burned $4.16M of free cash flow. Revenue fell 19.6% year over year.
As of its latest reported balance sheet, it holds $9.90M in cash and securities against $3.92M of debt, a net cash position of $5.98M.
AIM ImmunoTech does not currently pay a dividend.
The share price is down 93.3% over the past year. At $0.17 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $0.16 to $2.79, below its 200-day moving average of $0.55.
Frequently Asked Questions About AIM ImmunoTech
What is the current stock price for AIM?
As of the Oct 15, 2026 close, AIM stock trades at $0.17. The 52-week range is $0.16–$2.79, with a day range of $0.16–$0.18.
What is the P/E ratio for AIM?
The P/E ratio (Price-to-Earnings) for AIM is shown in the Key Statistics section. This valuation metric helps compare AIM ImmunoTech Inc. to industry peers.
Does AIM pay dividends?
AIM ImmunoTech does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for AIM?
Analyst ratings and recommendations for AIM are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of AIM?
As of the Oct 15, 2026 close, AIM ImmunoTech's market capitalization is $2.9M, classifying it as a micro-cap company. AIM ImmunoTech operates in the Healthcare sector within the Biotechnology industry.